Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Isolex 300i stem cell selection system: Pilot data; marketed in Europe

Of 9 patients who received allogeneic peripheral blood stem cell

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE